WinstonWınston
Docebo logo

Docebo

DCBO
56
Software - Application · Technology
Price
$20.38
+1.84 (+9.92%)
Market Cap
$517.3M
Exchange
NASDAQ
Winston Score
56
Winston is curious
A decent business — some strong pillars, some weaker.

Share count falling — buybacks

10.6% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 32.9M (2021) → 29.4M (2025)

Docebo is a software company that helps businesses train their employees, customers, and partners online. Its main product is a cloud-based learning management system (LMS) — basically a platform where companies can build, deliver, and track training courses. Customers are mostly mid-sized and large businesses across industries like technology, healthcare, and financial services.

Docebo makes money by charging companies a recurring subscription fee to use its platform, which gives it predictable revenue. It operates globally, with customers in over 90 countries, and generates most of its revenue in North America and Europe. Its moat comes from the sticky nature of LMS software — once a company builds its training programs inside a platform, switching is costly and disruptive. The key growth driver is the expanding corporate e-learning market, but the main risk is intense competition from larger software vendors like SAP, Cornerstone, and Workday, which have bigger sales teams and deeper customer relationships.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+12.9% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

-216.8% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$50M/ year

Rising (+14% vs prior year)

20.7% of revenue

In line with sector average (15%)

Investing heavily in future products and technology

Insider Activity

63.1%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$63M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Heavy R&D investment

Docebo is putting 21% of revenue into R&D and that number is rising. And they're generating enough cash to self-fund it.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
75.2%
Premium pricing power — 75.2% gross margin
Operating Margin
-0.1%
Losing money on operations — -0.1%
ROCE
-0.0%
Weak — -0.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+12.4%
Fast-growing sales (12.4% YoY)
EPS YoY
+59.9%
Earnings growing fast (59.9% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
128%
Turns 128% of profit into real cash
FCF Margin
17.4%
Converts sales into free cash efficiently (17.4%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
17.19x
Comfortably covers interest (17.2x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
16.8x
Fair value — P/E 16.8

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
+5.2
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (16.8 → 11.6)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial